Biologic Drugs

Aug 24, 2017
By Pharmaceutical Technology Editors
With £4.5 million (US$5.8 million) in funding, the consortium is tasked with developing a new automated continuous biologics purification unit to make biologic drug manufacturing more efficient.
Aug 24, 2017
By Pharmaceutical Technology Editors
FDA grants priority review for emicizumab, an investigational bispecific monoclonal antibody, for treating hemophilia A with factor VIII inhibitors.
Aug 21, 2017
By Pharmaceutical Technology Editors
The first program of this collaboration will focus on the development of a candidate for severe acute pancreatitis.
Aug 18, 2017
By Pharmaceutical Technology Editors
The withdrawal has been attributed to issues at the biotech company’s manufacturing facility.
Aug 18, 2017
By Pharmaceutical Technology Editors
FDA approves new molecular entity developed by Pfizer for treating a rare form of leukemia in adults.
Aug 15, 2017
By Pharmaceutical Technology Editors
The antibody therapeutic failed to meet its primary endpoint in a Phase III study.
Aug 07, 2017
By Pharmaceutical Technology Editors
The Washington-headquartered biotech firm plans to use the newly purchased facility to produce antibodies for its current and future pipeline.
Aug 04, 2017
By Pharmaceutical Technology Editors
Following passage by the House in July 2017, the Senate has voted to pass a reauthorization bill for FDA user-fee programs for drugs and medical devices ahead of the user-fee programs’ expiration date.
Aug 02, 2017
Pharmaceutical Technology
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
Aug 02, 2017
Pharmaceutical Technology
Safe and effective drug targeting with ADCs requires careful selection of drug, antibody, and linker.
native1_300x100
lorem ipsum